Patients with SGLT2 inhibitor-associated diabetic ketoacidosis (DKA) received significantly lower doses of insulin in the first 24 hours of treatment compared with patients with type 1 diabetes DKA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback